Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 10892
Country/Region: Vietnam
Year: 2009
Main Partner: To Be Determined
Main Partner Program: NA
Organizational Type: Implementing Agency
Funding Agency: USAID
Total Funding: $0

Funding for Treatment: ARV Drugs (HTXD): $0

Occasionally the Vietnam Administration for HIV/AIDS Control (VAAC) has requested PEPFAR Vietnam to

support its National Program. Vietnam's national ART program operates in provinces and districts not

covered by PEPFAR or the Global Fund. Support requested and provided to-date has consisted of the

provision of second-line ARV medicines in 2007. In addition, in 2008, PEPFAR had a surplus of first-line

medicines, which were offered to Vietnam's national ART program. VAAC then requested that PEPFAR

Vietnam provide assistance to supply both first- and second-line ARVs for an estimated 2,520 patients in

2008, and 3,000 patients in 2009. Per the terms of agreement, PEPFAR is involved in the selection and

monitoring of ART service sites to ensure treatment adherence and quality care. It is also involved in

monitoring the drug supply logistics.

PEPFAR has begun discussions to develop a plan for continued support of the national ART program after

September 2009. It is possible that VAAC will request continued support from PEPFAR for ARV drugs for

national program patients into calendar year 2010. To ensure there are resources available to meet the

need of these patients who are currently receiving ART, PEPFAR will reserve $680,000 to procure first-line

medicines in order to treat up to 4,000 patients. (Second-line medicines, for up to 200 patients, and

prevention of mother-to-child transmission (PMTCT) patient coverage for non-PEPFAR sites have already

been included in the Supply Chain Management System (SCMS) COP09 budget.)

New/Continuing Activity: New Activity

Continuing Activity:

Table 3.3.15: